| Financial Year |
March 31 2023 |
| Monetary Funds |
537,930,670.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
175,516,995.09 |
| Accounts Receivable |
182,851,996.73 |
| Advances to Suppliers |
3,191,942.67 |
| Other Receivables |
580,309.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,096,848,209.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,615,613.85 |
| Total Current Assets |
3,477,066,626.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
345,809,985.91 |
| Investment Properties |
-- |
| Fixed Assetes |
105,373,905.59 |
| Under-construction Projects |
364,734.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,346,052.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,515.00 |
| Deferred Income Tax Assets |
51,318,123.75 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
528,001,646.61 |
| Total Assets |
4,005,068,273.33 |
| Short-Term Loans |
219,163,254.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
346,199,954.73 |
| Accounts Payable |
92,874,821.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,652,122.00 |
| Taxes Payable |
55,210,371.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,851,659.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
901,949.30 |
| Other Current Liabilities |
96,103,109.47 |
| Sub-Total of Current Liabilities |
832,701,789.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
23,407,153.63 |
| Deferred Income Tax Liabilities |
4,189,568.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,790,264.87 |
| Total Liabilities |
864,492,054.04 |
| Paid-In Capital(Or Share Stock) |
980,888,981.00 |
| Capital Surplus |
740,083,090.07 |
| Surplus Reserve |
184,571,307.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,092,443,224.78 |
| Minority Stockholder's Interest |
102,814,112.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,037,762,107.24 |
| Owner's Equity（Stockholder's Equity） |
3,140,576,219.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,005,068,273.33 |
